Consistent with existing literature (10), our findings at baseline revealed that patients in the COPD with NAFLD group exhibited significantly higher median ALT levels compared to the COPD-only group (29.00 U/L vs. 22.50 U/L; p = 0.031), indicating a pre-existing metabolic disturbance. The gene discussed is GPT; the disease is chronic obstructive pulmonary disease.